ID

13604

Beschrijving

Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00513305

Link

https://clinicaltrials.gov/show/NCT00513305

Trefwoorden

  1. 19-02-16 19-02-16 -
Houder van rechten

CC BY-NC 3.0

Geüploaded op

19 februari 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Acute Myeloid Leukemia NCT00513305

Eligibility Acute Myeloid Leukemia NCT00513305

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patient has confirmed acute myeloid leukemia (aml).
Beschrijving

the patient has confirmed acute myeloid leukemia (aml).

Datatype

boolean

Alias
UMLS CUI [1]
C0023467
the patient is unwilling or unable to tolerate conventional induction chemotherapy.
Beschrijving

the patient is unwilling or unable to tolerate conventional induction chemotherapy.

Datatype

boolean

Alias
UMLS CUI [1]
C0392920
the patient has no comorbid conditions that would limit life expectancy to less than 3 months.
Beschrijving

the patient has no comorbid conditions that would limit life expectancy to less than 3 months.

Datatype

boolean

Alias
UMLS CUI [1]
C0023671
patient must meet specific laboratory parameters for study inclusion.
Beschrijving

patient must meet specific laboratory parameters for study inclusion.

Datatype

boolean

Alias
UMLS CUI [1]
C0022885
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
the patient has had previous cytotoxic chemotherapy for acute myeloid leukemia (aml) or myelodysplastic syndrome (mds).
Beschrijving

the patient has had previous cytotoxic chemotherapy for acute myeloid leukemia (aml) or myelodysplastic syndrome (mds).

Datatype

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0205156
previous treatment with low-dose cytarabine is not permitted.
Beschrijving

previous treatment with low-dose cytarabine is not permitted.

Datatype

boolean

Alias
UMLS CUI [1]
C0010711
the patient has a qt interval outside of the protocol-specified range.
Beschrijving

the patient has a qt interval outside of the protocol-specified range.

Datatype

boolean

Alias
UMLS CUI [1]
C0429028
the patient has laboratory values outside of protocol-specified ranges.
Beschrijving

the patient has laboratory values outside of protocol-specified ranges.

Datatype

boolean

Alias
UMLS CUI [1]
C0022885
the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.
Beschrijving

the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.

Datatype

boolean

Alias
UMLS CUI [1]
C0677881
UMLS CUI [2]
C0851346
UMLS CUI [3]
C1875319
the patient has uncontrolled, severe cardiovascular or pulmonary disease or other uncontrolled medical condition.
Beschrijving

the patient has uncontrolled, severe cardiovascular or pulmonary disease or other uncontrolled medical condition.

Datatype

boolean

Alias
UMLS CUI [1]
C0009488
the patient has known central nervous system involvement with aml.
Beschrijving

the patient has known central nervous system involvement with aml.

Datatype

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C0449389

Similar models

Eligibility Acute Myeloid Leukemia NCT00513305

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
acute myeloid leukemia
Item
the patient has confirmed acute myeloid leukemia (aml).
boolean
C0023467 (UMLS CUI [1])
conventional induction chemotherapy
Item
the patient is unwilling or unable to tolerate conventional induction chemotherapy.
boolean
C0392920 (UMLS CUI [1])
life expectancy
Item
the patient has no comorbid conditions that would limit life expectancy to less than 3 months.
boolean
C0023671 (UMLS CUI [1])
laboratory parameters
Item
patient must meet specific laboratory parameters for study inclusion.
boolean
C0022885 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
chemotherapy
Item
the patient has had previous cytotoxic chemotherapy for acute myeloid leukemia (aml) or myelodysplastic syndrome (mds).
boolean
C0392920 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
cytarabine
Item
previous treatment with low-dose cytarabine is not permitted.
boolean
C0010711 (UMLS CUI [1])
qt interval
Item
the patient has a qt interval outside of the protocol-specified range.
boolean
C0429028 (UMLS CUI [1])
laboratory values
Item
the patient has laboratory values outside of protocol-specified ranges.
boolean
C0022885 (UMLS CUI [1])
the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.
Item
the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.
boolean
C0677881 (UMLS CUI [1])
C0851346 (UMLS CUI [2])
C1875319 (UMLS CUI [3])
comorbidity
Item
the patient has uncontrolled, severe cardiovascular or pulmonary disease or other uncontrolled medical condition.
boolean
C0009488 (UMLS CUI [1])
central nervous system involvement
Item
the patient has known central nervous system involvement with aml.
boolean
C0023467 (UMLS CUI [1,1])
C0449389 (UMLS CUI [1,2])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial